Pharmacokinetic evaluation of a vapor-heated C1-inhibitor concentrate

被引：0
|
作者：
Waytes, AT
Peake, B
Engl, W
Wappler, N
Rosen, FS
机构：
[1] Bayer AG, Vienna, Austria
[2] Ctr Blood Res, Boston, MA 02115 USA
[3] Baxter Hyland Immuno, Rochester, MI USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2000年 / 105卷 / 01期
关键词：
D O I：
10.1016/S0091-6749(00)91100-X
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
672
引用
收藏
页码：S226 / S226
页数：1
相关论文
共 50 条
  • [41] INFUSION OF C1-INHIBITOR PLASMA CONCENTRATE PREVENTS HYPERAMYLASEMIA INDUCED BY ENDOSCOPIC SPHINCTEROTOMY
    TESTONI, PA
    CICARDI, M
    BERGAMASCHINI, L
    GUZZONI, S
    CUGNO, M
    BUIZZA, M
    BAGNOLO, F
    AGOSTONI, A
    GASTROINTESTINAL ENDOSCOPY, 1995, 42 (04) : 301 - 305
  • [42] A decade of human C1-inhibitor concentrate therapy in pediatric hereditary angioedema patients
    Farkas, H.
    Temesszentandrasi, G.
    Visy, B.
    Harmat, G.
    Varga, L.
    Fust, G.
    Szeplaki, G.
    Fekete, B.
    Karadi, I.
    Jakab, L.
    ALLERGY, 2007, 62 : 479 - 479
  • [43] C1-INHIBITOR FUNCTION AS A MARKER FOR HEREDITARY ANGIOEDEMA ACTIVITY IN PATIENTS ON SUBCUTANEOUS C1-INHIBITOR
    Levy, D.
    Riedl, M.
    Craig, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S90 - S90
  • [44] Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency
    Andrasi, Noemi
    Veszeli, Nora
    Holdonner, Agnes
    Temesszentandrasi, Gyorgy
    Kohalmi, Kinga Viktoria
    Varga, Lilian
    Farkas, Henriette
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
  • [45] SUCCESSFUL OUTCOME USING C1-INHIBITOR CONCENTRATE IN ACUTE PANCREATITIS CAUSED BY HEREDITARY ANGIOEDEMA
    Vitito, LeAnne
    Czaller, Ibolya
    Molnar, Katalin
    Csuka, Dorottya
    Varga, Lilian
    Farkas, Henriette
    GASTROENTEROLOGY NURSING, 2011, 34 (01) : 60 - 63
  • [46] A clinical study on pharmacokinetics of pasteurized C1-inhibitor concentrate in patients with hereditary angioedema (HAE).
    Martinez-Saguer, I
    Müller, W
    Salem, H
    Escuriola-Ettingshausen, C
    Klarmann, D
    Kreuz, W
    BLOOD, 2000, 96 (11) : 642A - +
  • [47] Manufacturing of plasma-derived C1-inhibitor concentrate for treatment of patients with hereditary angioedema
    Simon, Toby L.
    Kalina, Uwe
    Laske, Reiner
    Mycroft, Sarah
    Widmer, Eleonora
    Roth, Nathan J.
    ALLERGY AND ASTHMA PROCEEDINGS, 2020, 41 (02) : 99 - 107
  • [48] Over 10 years of experience with the use of C1-inhibitor concentrate in hereditary angioedema, in retrospect
    Farkas, H.
    Temesszentandrasi, G.
    Visy, B.
    Harmat, G.
    Varga, L.
    Fuest, G.
    Szeplaki, G.
    Karadi, I.
    Fekete, B.
    Jakab, L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S311 - S311
  • [49] C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option
    Longhurst, H. J.
    Carr, S.
    Khair, K.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 147 (01): : 11 - 17
  • [50] Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate
    Riedl, Marc A.
    Hinds, David R.
    Prince, Patricia M.
    Alvord, Trevor M.
    Dosenovic, Sara
    Abdelhadi, Jenna F.
    Brownrigg, Jack R.
    Camp, Charlotte L.
    Machnig, Thomas
    Banerji, Aleena
    ALLERGY AND ASTHMA PROCEEDINGS, 2023, 44 (04) : 275 - 282
12345